Please wait a minute...
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Front Med    2012, Vol. 6 Issue (4) : 354-359     DOI: 10.1007/s11684-012-0234-2
REVIEW |
The genetics of Beh?et’s disease in a Chinese population
Shengping Hou1,2, Aize Kijlstra3, Peizeng Yang1,2()
1. The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China; 2. Chongqing Eye Institute and Chongqing Key Laboratory of Ophthalmology, Chongqing 400016, China; 3. University Eye Clinic Maastricht, Maastricht, Limburg, the Netherlands
Download: PDF(134 KB)   HTML
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract  

Beh?et’s disease is defined as a multisystemic inflammatory disease. Although the precise pathogenesis and etiology is still a mystery, accumulating evidence shows that genetic variants of immune-related genes have a profound influence on the development of Beh?et’s disease. To explore the genetic factors for Beh?et’s disease, our group investigated the association of Beh?et’s disease with multiple immune response genes and has identified multiple Beh?et’s disease-related immunoregulatory pathways in the Chinese Han population. A large number of gene polymorphisms were studied including STAT4, IL23R, CD40, CCR1/CCR3, STAT3, OPN, IL17, JAK2, MCP-1, CTLA4, PD-1, PD-L1, PD-L2, TGRBR3, CCR6, PTPN22, FCRL3, IRF5, SUMO4 and UBAC2. Significant associations were found between Beh?et’s disease and STAT4, IL23R, CD40, CCR1/CCR3, STAT3, MCP-1, TGFBR3, FCRL3, SUMO4, UBAC2. These genetic predisposition studies support an important role for both lymphocyte differentiation as well as ubiquitination pathways. These findings are helpful in elucidating the pathogenesis of Beh?et’s disease and hopefully will allow the development of novel treatment regimes.

Keywords Beh?et’s disease      SNPs      immune gene      genetic study     
Corresponding Authors: Yang Peizeng,Email:peizengycmu@126.com   
Issue Date: 05 December 2012
URL:  
http://academic.hep.com.cn/fmd/EN/10.1007/s11684-012-0234-2     OR     http://academic.hep.com.cn/fmd/EN/Y2012/V6/I4/354
GeneSNPsAllele/genotypeP valueORReference
HLA-B51--2.54 × 10-65.94[9]
CD40rs4810485TT0.0061.98[26]
rs1883832TT0.0121.73
CCR1/CCR3rs13084057G1.71 × 10-70.32[36]
rs13092160C6.50 × 10-80.28
rs13075270C2.76 × 10-70.32
H3GTGAC7.79 × 10-40.16
H6CCATTA2.70 × 10-30.15
STAT4rs7574865GG0.0091.61[38]
rs897200A6.20 × 10-91.45[39]
rs7574070T3.36 × 10-71.40
rs7572482T1.30 × 10-81.44
IL23Rrs17375018G8.88 × 10-41.57[41]
GG3.47 × 10-41.86
rs11209032G1.26 × 10-30.67
GG0.0120.56
STAT3rs2293152GG0.0211.71[42]
TGFBR3rs1805110CC0.030.62[48]
MCP-1-2518 A/GAA0.0480.64[46]
UBAC2rs3825427T6.90 × 10-61.5[50]
rs9517668T3.30 × 10-41.4
rs9517701G2.90 × 10-51.4
SUMO4 + 438 C→TC0.0021.7[9]
CC0.010-
FCRL3- 110 A→GA0.0440.7[51]
Tab.1  The summary of the associated genes of Behcet’s disease in the Chinese Han population
1 Smyth DJ, Plagnol V, Walker NM, Cooper JD, Downes K, Yang JH, Howson JM, Stevens H, McManus R, Wijmenga C, Heap GA, Dubois PC, Clayton DG, Hunt KA, van Heel DA, Todd JA. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med 2008; 359(26): 2767-2777
doi: 10.1056/NEJMoa0807917 pmid:19073967
2 Evereklioglu C. Current concepts in the etiology and treatment of Beh?et disease. Surv Ophthalmol 2005; 50(4): 297-350
doi: 10.1016/j.survophthal.2005.04.009 pmid:15967189
3 James DG. Silk Route disease. Postgrad Med J 1986; 62(725): 151-153
doi: 10.1136/pgmj.62.725.151 pmid:3714598
4 Yoshida A, Kawashima H, Motoyama Y, Shibui H, Kaburaki T, Shimizu K, Ando K, Hijikata K, Izawa Y, Hayashi K, Numaga J, Fujino Y, Masuda K, Araie M. Comparison of patients with Beh?et’s disease in the 1980s and 1990s. Ophthalmology 2004; 111(4): 810-815
doi: 10.1016/j.ophtha.2003.07.018 pmid:15051217
5 Yang P, Zhang Z, Zhou H, Li B, Huang X, Gao Y, Zhu L, Ren Y, Klooster J, Kijlstra A. Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China. Curr Eye Res 2005; 30(11): 943-948
doi: 10.1080/02713680500263606 pmid:16282128
6 Escudier M, Bagan J, Scully C. Number VII Beh?et’s disease (Adamantiades syndrome). Oral Dis 2006; 12(2): 78-84
doi: 10.1111/j.1601-0825.2005.01144.x pmid:16476027
7 Azizlerli G, K?se AA, Sarica R, Gül A, Tutkun IT, Kula? M, Tun? R, Urgancio?lu M, Di??i R. Prevalence of Beh?et’s disease in Istanbul, Turkey. Int J Dermatol 2003; 42(10): 803-806
doi: 10.1046/j.1365-4362.2003.01893.x pmid:14521694
8 Gül A. Beh?et’s disease as an autoinflammatory disorder. Curr Drug Targets Inflamm Allergy 2005; 4(1): 81-83
doi: 10.2174/1568010053622894 pmid:15720240
9 Hou S, Yang P, Du L, Zhou H, Lin X, Liu X, Kijlstra A. SUMO4 gene polymorphisms in Chinese Han patients with Beh?et's disease. Clin Immunol 2008; 129(1):170-175
pmid:18657476
10 de Menthon M, Lavalley MP, Maldini C, Guillevin L, Mahr A. HLA-B51/B5 and the risk of Beh?et’s disease: a systematic review and meta-analysis of case-control genetic association studies. Arthritis Rheum 2009; 61(10): 1287-1296
doi: 10.1002/art.24642 pmid:19790126
11 Krause L, K?hler AK, Altenburg A, Papoutsis N, Zouboulis CC, Pleyer U, Stroux A, Foerster MH. Ocular involvement is associated with HLA-B51 in Adamantiades-Beh?et’s disease. Eye (Lond) 2009; 23(5): 1182-1186
doi: 10.1038/eye.2008.177 pmid:18551141
12 Gül A, Hajeer AH, Worthington J, Barrett JH, Ollier WE, Silman AJ. Evidence for linkage of the HLA-B locus in Beh?et’s disease, obtained using the transmission disequilibrium test. Arthritis Rheum 2001; 44(1): 239-240
doi: 10.1002/1529-0131(200101)44:1<239::AID-ANR31>3.0.CO;2-X pmid:11212166
13 Mizuki N, Ota M, Katsuyama Y, Yabuki K, Ando H, Shiina T, Nomura E, Onari K, Ohno S, Inoko H. HLA-B*51 allele analysis by the PCR-SBT method and a strong association of HLA-B*5101 with Japanese patients with Beh?et’s disease. Tissue Antigens 2001; 58(3): 181-184
doi: 10.1034/j.1399-0039.2001.580306.x pmid:11703826
14 Li H, Yang P, Jiang Z, Hou S, Xie L. Lack of association of two polymorphisms of IRF5 with Beh?et’s disease. Mol Vis 2009; 15: 2018-2021
pmid:19816589
15 Kelly JA, Kelley JM, Kaufman KM, Kilpatrick J, Bruner GR, Merrill JT, James JA, Frank SG, Reams E, Brown EE, Gibson AW, Marion MC, Langefeld CD, Li QZ, Karp DR, Wakeland EK, Petri M, Ramsey-Goldman R, Reveille JD, Vilá LM, Alarcón GS, Kimberly RP, Harley JB, Edberg JC. Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African Americans. Genes Immun 2008; 9(3): 187-194
doi: 10.1038/gene.2008.4 pmid:18288123
16 Dideberg V, Kristjansdottir G, Milani L, Libioulle C, Sigurdsson S, Louis E, Wiman AC, Vermeire S, Rutgeerts P, Belaiche J, Franchimont D, Van Gossum A, Bours V, Syv?nen AC. An insertion-deletion polymorphism in the interferon regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases. Hum Mol Genet 2007; 16(24): 3008-3016
doi: 10.1093/hmg/ddm259 pmid:17881657
17 Rueda B, Reddy MV, González-Gay MA, Balsa A, Pascual-Salcedo D, Petersson IF, Eimon A, Paira S, Scherbarth HR, Pons-Estel BA, González-Escribano MF, Alarcón-Riquelme ME, Martín J. Analysis of IRF5 gene functional polymorphisms in rheumatoid arthritis. Arthritis Rheum 2006; 54(12): 3815-3819
doi: 10.1002/art.22271 pmid:17133578
18 Kristjansdottir G, Sandling JK, Bonetti A, Roos IM, Milani L, Wang C, Gustafsdottir SM, Sigurdsson S, Lundmark A, Tienari PJ, Koivisto K, Elovaara I, Pirttil? T, Reunanen M, Peltonen L, Saarela J, Hillert J, Olsson T, Landegren U, Alcina A, Fernández O, Leyva L, Guerrero M, Lucas M, Izquierdo G, Matesanz F, Syv?nen AC. Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations. J Med Genet 2008; 45(6): 362-369
doi: 10.1136/jmg.2007.055012 pmid:18285424
19 Zhang Q, Hou S, Jiang Z, Du L, Li F, Xiao X, Kijlstra A, Yang P. No association of PTPN22 polymorphisms with susceptibility to ocular Beh?et’s disease in two Chinese Han populations. PLoS ONE 2012; 7(3): e31230
doi: 10.1371/journal.pone.0031230 pmid:22396730
20 Baranathan V, Stanford MR, Vaughan RW, Kondeatis E, Graham E, Fortune F, Madanat W, Kanawati C, Ghabra M, Murray PI, Wallace GR. The association of the PTPN22 620W polymorphism with Beh?et’s disease. Ann Rheum Dis 2007; 66(11): 1531-1533
doi: 10.1136/ard.2007.073866 pmid:17660222
21 Du L, Yang P, Hou S, Zhou H, Kijlstra A. No association of CTLA-4 polymorphisms with susceptibility to Beh?et disease. Br J Ophthalmol 2009; 93(10): 1378-1381
doi: 10.1136/bjo.2008.156919 pmid:19570770
22 Zhang YJ, Xu WD, Duan ZH, Liu SS, Pan HF, Ye DQ.Lack of association between CTLA-4+49A/G and -318C/T polymorphisms and Beh?et's disease risk: a meta-analysis. Clin Exp Rheumatol 2012Sep25. [Epub ahead of print]
pmid:23010350
23 Bye L, Modi N, Stanford MR, Kondeatis E, Vaughan R, Fortune F, Kanawati C, Ben-Chetrit E, Ghabra M, Murray PI, Wallace GR. CTLA-4 polymorphisms are not associated with ocular inflammatory disease. Tissue Antigens 2008; 72(1): 49-53
doi: 10.1111/j.1399-0039.2008.01062.x pmid:18498289
24 Ben Dhifallah I, Chelbi H, Braham A, Hamzaoui K, Houman MH. CTLA-4+49A/G polymorphism is associated with Beh?et’s disease in a Tunisian population. Tissue Antigens 2009; 73(3): 213-217
doi: 10.1111/j.1399-0039.2008.01186.x pmid:19254250
25 Xu Y, Song G. The role of CD40-CD154 interaction in cell immunoregulation. J Biomed Sci 2004; 11(4): 426-438
doi: 10.1007/BF02256091 pmid:15153777
26 Chen F, Hou S, Jiang Z, Chen Y, Kijlstra A, Rosenbaum JT, Yang P. CD40 gene polymorphisms confer risk of Beh?et’s disease but not of Vogt-Koyanagi-Harada syndrome in a Han Chinese population. Rheumatology (Oxford) 2012; 51(1): 47-51
doi: 10.1093/rheumatology/ker345 pmid:22087016
27 Raychaudhuri S, Remmers EF, Lee AT, Hackett R, Guiducci C, Burtt NP, Gianniny L, Korman BD, Padyukov L, Kurreeman FA, Chang M, Catanese JJ, Ding B, Wong S, van der Helm-van Mil AH, Neale BM, Coblyn J, Cui J, Tak PP, Wolbink GJ, Crusius JB, van der Horst-Bruinsma IE, Criswell LA, Amos CI, Seldin MF, Kastner DL, Ardlie KG, Alfredsson L, Costenbader KH, Altshuler D, Huizinga TW, Shadick NA, Weinblatt ME, de Vries N, Worthington J, Seielstad M, Toes RE, Karlson EW, Begovich AB, Klareskog L, Gregersen PK, Daly MJ, Plenge RM. Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat Genet 2008; 40(10): 1216-1223
doi: 10.1038/ng.233 pmid:18794853
28 Keir ME, Butte MJ, Freeman GJ, Sharpe AH. PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 2008; 26(1): 677-704
doi: 10.1146/annurev.immunol.26.021607.090331 pmid:18173375
29 Meng Q, Guo H, Hou S, Jiang Z, Kijlstra A, Yang P. Lack of an association of PD-1 and its ligand genes with Beh?et’s disease in a Chinese Han population. PLoS ONE 2011; 6(10): e25345
doi: 10.1371/journal.pone.0025345 pmid:22039410
30 Kong EK, Prokunina-Olsson L, Wong WH, Lau CS, Chan TM, Alarcón-Riquelme M, Lau YL. A new haplotype of PDCD1 is associated with rheumatoid arthritis in Hong Kong Chinese. Arthritis Rheum 2005; 52(4): 1058-1062
doi: 10.1002/art.20966 pmid:15818672
31 Kroner A, Mehling M, Hemmer B, Rieckmann P, Toyka KV, M?urer M, Wiendl H. A PD-1 polymorphism is associated with disease progression in multiple sclerosis. Ann Neurol 2005; 58(1): 50-57
doi: 10.1002/ana.20514 pmid:15912506
32 Prokunina L, Castillejo-López C, Oberg F, Gunnarsson I, Berg L, Magnusson V, Brookes AJ, Tentler D, Kristjansdóttir H, Gr?ndal G, Bolstad AI, Svenungsson E, Lundberg I, Sturfelt G, J?nssen A, Truedsson L, Lima G, Alcocer-Varela J, Jonsson R, Gyllensten UB, Harley JB, Alarcón-Segovia D, Steinsson K, Alarcón-Riquelme ME. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet 2002; 32(4): 666-669
doi: 10.1038/ng1020 pmid:12402038
33 Di Marzio P, Dai WW, Franchin G, Chan AY, Symons M, Sherry B. Role of Rho family GTPases in CCR1- and CCR5-induced actin reorganization in macrophages. Biochem Biophys Res Commun 2005; 331(4): 909-916
doi: 10.1016/j.bbrc.2005.04.015 pmid:15882964
34 Saeki T, Naya A. CCR1 chemokine receptor antagonist. Curr Pharm Des 2003; 9(15): 1201-1208
doi: 10.2174/1381612033454937 pmid:12769747
35 Penido C, Castro-Faria-Neto HC, Vieira-de-Abreu A, Figueiredo RT, Pelled A, Martins MA, Jose PJ, Williams TJ, Bozza PT. LPS induces eosinophil migration via CCR3 signaling through a mechanism independent of RANTES and Eotaxin. Am J Respir Cell Mol Biol 2001; 25(6): 707-716
pmid:11726396
36 Hou S, Xiao X, Li F, Jiang Z, Kijlstra A, Yang P. Two-stage association study in Chinese Han identifies two independent associations in CCR1/CCR3 locus as candidate for Beh?et’s disease susceptibility. Hum Genet 2012Jul25. [Epub ahead of print]
doi: 10.1007/s00439-012-1200-4 pmid:10.1007/s00439-012-1200-422829007" target="blank">
doi: 10.1007/s00439-012-1200-422829007
37 Kirino Y, Bertsias G, Ombrello MJ, Ustek D, Satorius C, Le J, Mizuki N, Ishigatsubo Y, Seyahi E, Sacli FS, Gul A, Kastner DL, Remmers E.Genome-Wide Analysis of Imputed Genotypes Identifies Chemokine Receptor-1 CCR1) As a Novel Candidate Risk Locus in Beh?et's Disease. Arthritis Rheum 2011; 63(10): S946
38 Hu K, Yang P, Jiang Z, Hou S, Du L, Li F. STAT4 polymorphism in a Chinese Han population with Vogt-Koyanagi-Harada syndrome and Beh?et’s disease. Hum Immunol 2010; 71(7): 723-726
doi: 10.1016/j.humimm.2010.04.007 pmid:20438790
39 Hou S, Yang Z, Du L, Jiang Z, Shu Q, Chen Y, Li F, Zhou Q, Ohno S, Chen R , Kijlstra A, Rosenbaum JT, Yang P. Genome-wide association study identifies susceptible locus in STAT4 for Beh?et's disease in Han Chinese. Arthritis Rheum 2012Sep22.[Epub ahead of print]
doi: 10.1002/art.37708 pmid:.23001997
40 Chu M, Yang P, Hou S, Li F, Chen Y, Kijlstra A. Beh?et’s disease exhibits an increased osteopontin serum level in active stage but no association with osteopontin and its receptor gene polymorphisms. Hum Immunol 2011; 72(6): 525-529
doi: 10.1016/j.humimm.2011.03.016 pmid:21513757
41 Jiang Z, Yang P, Hou S, Du L, Xie L, Zhou H, Kijlstra A. IL-23R gene confers susceptibility to Beh?et’s disease in a Chinese Han population. Ann Rheum Dis 2010; 69(7): 1325-1328
doi: 10.1136/ard.2009.119420 pmid:20375120
42 Hu K, Hou S, Jiang Z, Kijlstra A, Yang P. JAK2 and STAT3 polymorphisms in a Han Chinese population with Beh?et’s disease. Invest Ophthalmol Vis Sci 2012; 53(1): 538-541
doi: 10.1167/iovs.11-8440 pmid:22205606
43 Shu Q, Yang P, Hou S, Li F, Chen Y, Du L, Jiang Z. Interleukin-17 gene polymorphism is associated with Vogt-Koyanagi-Harada syndrome but not with Beh?et’s disease in a Chinese Han population. Hum Immunol 2010; 71(10): 988-991
doi: 10.1016/j.humimm.2010.06.020 pmid:20620187
44 Mizuki N, Meguro A, Ota M, Ohno S, Shiota T, Kawagoe T, Ito N, Kera J, Okada E, Yatsu K, Song YW, Lee EB, Kitaichi N, Namba K, Horie Y, Takeno M, Sugita S, Mochizuki M, Bahram S, Ishigatsubo Y, Inoko H. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Beh?et’s disease susceptibility loci. Nat Genet 2010; 42(8): 703-706
doi: 10.1038/ng.624 pmid:20622879
45 Remmers EF, Cosan F, Kirino Y, Ombrello MJ, Abaci N, Satorius C, Le JM, Yang B, Korman BD, Cakiris A, Aglar O, Emrence Z, Azakli H, Ustek D, Tugal-Tutkun I, Akman-Demir G, Chen W, Amos CI, Dizon MB, Kose AA, Azizlerli G, Erer B, Brand OJ, Kaklamani VG, Kaklamanis P, Ben-Chetrit E, Stanford M, Fortune F, Ghabra M, Ollier WE, Cho YH, Bang D, O’Shea J, Wallace GR, Gadina M, Kastner DL, Gül A. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Beh?et’s disease. Nat Genet 2010; 42(8): 698-702
doi: 10.1038/ng.625 pmid:20622878
46 Hou S, Yang P, Du L, Jiang Z, Mao L, Shu Q, Zhou H, Kijlstra A. Monocyte chemoattractant protein-1-2518 A/G single nucleotide polymorphism in Chinese Han patients with ocular Beh?et’s disease. Hum Immunol 2010; 71(1): 79-82
doi: 10.1016/j.humimm.2009.09.354 pmid:19782713
47 Yi X, Yang P, Du L, Jiang Z, Li F. There is no association of CCR6 polymorphisms with susceptibility to Beh?et’s disease in two Chinese Han populations. Br J Ophthalmol 2011; 95(11): 1603-1606
doi: 10.1136/bjophthalmol-2011-300018 pmid:21873313
48 Chen Y, Yang P, Li F, Hou S, Jiang Z, Shu Q, Kijlstra A. Association analysis of TGFBR3 gene with Vogt-Koyanagi-Harada disease and Beh?et’s disease in the Chinese Han population. Curr Eye Res 2012; 37(4): 312-317
doi: 10.3109/02713683.2011.635398 pmid:22440163
49 Fei Y, Webb R, Cobb BL, Direskeneli H, Saruhan-Direskeneli G, Sawalha AH. Identification of novel genetic susceptibility loci for Beh?et’s disease using a genome-wide association study. Arthritis Res Ther 2009; 11(3): R66
doi: 10.1186/ar2695 pmid:19442274
50 Hou S, Shu Q, Jiang Z, Chen Y, Li F, Chen F, Kijlstra A, Yang P. Replication study confirms the association between UBAC2 and Beh?et’s disease in two independent Chinese sets of patients and controls. Arthritis Res Ther 2012; 14(2): R70
doi: 10.1186/ar3789 pmid:22455605
51 Sawalha AH, Hughes T, Nadig A, Y?lmaz V, Aksu K, Keser G, Cefle A, Yaz?c? A, Ergen A, Alarcón-Riquelme ME, Salvarani C, Casali B, Direskeneli H, Saruhan-Direskeneli G. A putative functional variant within the UBAC2 gene is associated with increased risk of Beh?et’s disease. Arthritis Rheum 2011; 63(11): 3607-3612
doi: 10.1002/art.30604 pmid:21918955
52 Fakhfakh Karray E, Bendhifallah I, Zakraoui L, Hamzaoui K. Association of small ubiquitin-like modifier 4 gene polymorphisms with rheumatoid arthritis in a Tunisian population. Clin Exp Rheumatol 2011; 29(4): 751
pmid:21906435
53 Park G, Kim HS, Choe JY, Kim SK. SUMO4 C438T polymorphism is associated with papulopustular skin lesion in Korean patients with Beh?et’s disease. Rheumatol Int 2012 ;32(10):3031-3037
pmid:21901353
54 .Li K, Zhao M, Hou S, Du L, Kijlstra A, Yang P. Association between polymorphisms of FCRL3, a non-HLA gene, and Beh?et’s disease in a Chinese population with ophthalmic manifestations. Mol Vis 2008; 14: 2136-2142
pmid:19050767
No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed